The timing of this webinar on January 11 was very deliberate as it marks one year and one day from the full implementation of the EU HTA Regulation for oncology products, ATMPs and certain medical devices. How prepared are you feeling?
Watch the recording of the webinar to learn what we know about the regulation so far and how biopharmaceutical companies should be preparing.
The webinar covers:
- EU HTA regulation progress to date
- The impact at a Member State level
- How pharmaceutical companies should be preparing
- The intersection of the EU HTA Regulation and draft EU pharmaceutical legislation
Hear from Suzette Matthijsse, Senior Director and EU Head of Modelling & Analytics, and independent access consultant, Neil Grubert, as they discuss important updates and how to best prepare for the EU HTA regulation.
